Identification of a novel mutation in the CACNA1C gene in a Chinese family with autosomal dominant cerebellar ataxia

doi:10.21203/rs.2.9243/v2

Download PDF

Research article

Identification of a novel mutation in the CACNA1C gene in a Chinese family with autosomal dominant cerebellar ataxia

https://doi.org/10.21203/rs.2.9243/v2

This work is licensed under a CC BY 4.0 License

Journal Publication

published 10 Jul, 2019

Read the published version in BMC Neurology →

You are reading this older preprint version

Read the latest preprint version →

Background: Hereditary ataxia is a group of neurodegenerative diseases with progressive cerebellar ataxia of the gait and limbs as the main symptoms. The genetic patterns of the disease are diverse but it is mainly divided into autosomal dominant cerebellar ataxia (ADCA) and autosomal recessive cerebellar ataxia (ARCA), and about 45 pathogenic loci have been found in ADCA. The purpose of this study was to explore the genetic defect in a Chinese family with ADCA. Methods: A three-generation Chinese family with ADCA was enrolled in this study, Exome sequencing was conducted in four family members, including the proband, and verified by Sanger sequencing. Results: The rs779393130 mutation of the CACNA1C gene co-segregated with the ataxia phenotype in this family. The mutation was not detected in 50 unaffected controls. Conclusions: The rs779393130 mutation of CACNA1C may be associated with the phenotype of the disease. The CACNA1C gene encodes the Cav1.2 (alpha-1) subunit of an L-type calcium channel and this subunit may be related to the ADCA phenotype. These findings may have implications for family clinical monitoring and genetic counseling and may also help in understanding pathogenesis of this disease.

Internal Medicine Specialties

hereditary ataxia

ADCA

L-type calcium channel

CACNA1C

mutation

Hereditary ataxia (HA) is a group of neurodegenerative diseases with progressive cerebellar ataxia of the gait and limbs as the main symptoms; HA affects the cerebellum, brainstem, spinal cord, and cranial nerve nuclei^[1]. It is a highly genetically and clinically heterogeneous disease that accounts for about 10% to 15% of nervous system genetic disorders. The genetic patterns of the disease are diverse: mainly autosomal dominant, partly autosomal recessive, and a few cases of X-linked or mitochondrial inheritance ^[2,3]. To date, about 45 pathogenic loci have been found in autosomal dominant cerebellar ataxia (ADCA), 35 of which have been cloned, and 70 pathogenic loci have been found in autosomal recessive cerebellar ataxia (ARCA), at least 50 of which have been cloned ^[4].

Clinical manifestations of the different HA subtypes are similar, making simple diagnosis difficult ^[5]. Thus, genetic testing has proven to be very valuable for patients with HA. Genetic testing techniques are currently the most efficient tools for HA diagnosis and classification. Genotypic phenotypic correlation analysis can be challenging because of background genetic or environmental factors. Identifying the causative genes can help us understand the pathogenesis of diseases, such as neuronal growth, differentiation, morphogenesis, migration, and tissue formation ^[6,7]. The purpose of this study was to explore the genetic defect in a Chinese family with ADCA.

The Cav1.2 protein encoded by the CACNA1C gene is the main component of the L-type voltage-gated calcium channel (LTCC). The characteristics of the Cav1.2 channel, such as channel sensitivity, ion selectivity, and drug reaction with calcium ion, are encoded by CACNA1C. Polymorphisms in CACNA1C are associated with mental disorders, epilepsy, and migraine. It has been reported that the content of Cav1.2 protein in the cerebellum is significantly altered in mice with ataxia and epilepsy. The function of CACNA1C gene may be related to ataxia. Consistent with reports that mutations in channel-encoding genes may cause ADCA, we proposed that a novel mutation in CACNA1C (rs779393130) may be related to ADCA in this family.

Pedigree and subjects

This study included three generations of a Chinese family with ADCA. All available individuals underwent a thorough neurological examination by two or more experienced neurologists. All patients were diagnosed at the China-Japan Union Hospital of Jilin University. If the individuals exhibited progressive ataxia, they were considered to be affected. Other information on the age of onset, symptoms at the time of onset, magnetic resonance imaging (MRI) results, Montreal Cognitive Assessment (MoCA) scale, and Scale for the Assessment and Rating of Ataxia (SARA), was obtained. Fifty unrelated, ethnically matched controls (male/female: 25/25, age 35.4 ± 8.9 years) without diagnostic features of ADCA were recruited from the same region. The study was conducted in accordance with the Declaration of Helsinki Principles and approved by the ethics committee of the China-Japan Union Hospital of Jilin University. After obtaining informed consent from all subjects, we obtained venous blood samples from affected and unaffected family members (II-1, II-3, II-5, II-6, II-7, III-3, III-4, III-5) and from the 50 unrelated, ethnically matched, unaffected controls for isolation of genomic DNA. The genetic panel for SCA was performed in the proband and his son, and the common mutations and locations of SCA subtypes were excluded by fluorescence labeled capillary electrophoresis fragment analysis. And then, we chose Exome sequencing to explore the genetic defect in this family.

Whole-exome sequencing and bioinformatics analysis

Whole-exome sequencing was performed in the proband (II-5) and his sibling (II-7), son (III-4), and niece (III-5). A standard phenol-chloroform extraction method was used to extract genomic DNA from peripheral blood. Whole-exome sequencing was performed by Novogene Bioinformatics Institute. Following the manufacturer’s procedures, more than 1.5 μg of genomic DNA from each sampled individual was cut by using a sonicator (Covaris); enriched, hybridized, and captured on the Agilent SureSelect Human All Exon V5; and sequenced using the Illumina HiSeq 2000 sequencer (Illumina Inc., San Diego, CA, USA). The average sequencing depth of 57.36× provided sufficient depth to exactly call variants at 97.2% of targeted exome.

Clean reads without adaptors or degraded readings were mapped to the human reference genome (UCSC hg19) using the Burrows-Wheeler alignment (BWA) tool. Single nucleotide polymorphism (SNP) and insertions/deletions were identified by sequence alignment/map tools and then the identification process was repeated using Picard tag reading. We screened all variants against the SNP database, 1000 Genomes project, and the outer NHLBI exome sequencing projects (ESP) 6500. Functional prediction was carried out by Sorting Intolerant from Tolerant (SIFT) and Polymorphism Phenotyping version 2 (PolyPhen-2). Candidate variants were annotated by the ANNOVAR (Annotate Variation) software.

Bioinformatics analysis is mainly based on the screening of candidate genes and their relationship with disease phenotypes. Firstly, candidate gene enrichment analysis is carried out. Through GO function enrichment analysis, three results are generated: cell components, biological pathways and molecular functions. Then KEGG pathway enrichment is carried out. Significant enrichment analysis was used to identify the major biochemical metabolic pathways and signal transduction pathways in which mutant genes participated. Then, gene-disease phenotype correlation analysis was performed. Phenolyzer analysis was performed based on the candidate genes and disease/phenotype names obtained from the previous analysis. Candidate genes are mainly based on harmful classification, dominant and recessive pattern screening and other analysis of screened genes, and the disease and genes are input for analysis on the Phenolyzer website. According to the reports in OMIM, NCBI's ClinVar, GeneReviews and HPRD, the correlation between disease and gene was analyzed. Phenolyzer software scored the correlation of diseases and genes in the database, and ranked the correlation by the final scoring results.

Direct Sanger sequencing

According to the bioinformatics results, we identified the top 3 candidate pathogenic genes: very low density lipoprotein receptor (VLDLR), aldehyde dehydrogenase 5 family member A1 (ALDH5A1), and calcium voltage-gated channel subunit alpha1 C (CACNA1C). Direct Sanger sequencing was then performed using an ABI 3500 sequencer (Applied Biosystems, Foster City, CA, USA) to identify the top three potential causative variants we have set out from bioinformatics analysis in the family. The primer sequences for the pathogenic variants in the genes were designed as follows. For CACNA1C (rs779393130): 5′-CCACGGCTTCCTCGAATCTTG-3′ and 5′-GGGAATTTTCCGCTCCGTCTC-3′; for VLDLR (NM_003383: exon16:c.2252-8->AA): 5′-ACCGACTGTCCTTCCCAAAGT-3′ and 5′-CACCAGGAACAACTCTGGCTTA-3′; and for ALDH5A1 (rs147358733): 5′-TTCTGCAGTTTAAACATTCTAAAAGA-3′ and 5′-TCAGGGTTTCCTATGTTCTCTTC-3′. Mutation Taster (www.mutationtaster.org) was applied to predict the function of genetically pathogenic variants. We first performed Sanger sequencing on affected and unaffected family members (II-1, II-3, II-5, II-6, II-7, III-3, III-4, III-5). Then, Sanger sequencing was performed on 50 unaffected individuals to detect the CACNA1C gene variant rs779393130.

Clinical findings

The family we enrolled was a three-generation Chinese family with autosomal dominant inheritance of ataxia; the pedigree is shown in Figure 1. Exome sequencing was performed in the proband (II-5) and his brother (II-7), son (III-4), and niece (III-5).

The five affected family members alive all developed gait disturbance, and three of them developed difficulties in speech and smooth pursuit defects around the age of 30. They also had disease-causing mutations. The clinical characteristics are shown in Table 1.

Neuroradiological examination showed that atrophy was limited to the cerebellum of two individuals we can get (Figure 2). Therefore, they were diagnosed as pure cerebellar ataxia.

Exome sequencing

Sequence data quality of four members of this family are shown in Table 2. Known variants with a minor allele frequency (MAF) >1% identified in dbSNP142, the frequency of 1000 genome plans is >0.5%, filtering out NHLBI ESP6500. Complex diseases are generally not caused by mutations in a single gene or allele but may involve multiple genes or pathways. Based on, we constructed associations among genes, phenotypes, and diseases by precise algorithms, sequencing results, and multiple databases.

Phenolyzer analysis was performed based on candidate genes (genes screened based on harmful classification, dominant and recessive pattern screening, etc.) and disease/phenotype names (diseases and genes were entered into Phenolyzer website for analysis). According to the reports in OMIM, NCBI's ClinVar, GeneReviews, HPRD and other databases, the correlation between disease and gene was analyzed (Figure 3). Phenolyzer software scored the correlation based on the information of diseases and genes in the database, and ranked the correlation based on the final scoring results (Figure 4). From the figures, it can be seen that differences related to ataxia are significant, and genes with strong correlations are VLDLR, ALDH5A1, and CACNA1C, and strong correlations means these correlations between gene variants and ataxia (or phenotype).

Identification of the pathogenic mutation

As candidate genes selected by the whole-exome sequencing, VLDLR, ALDH5A1, and CACNA1C were sequenced by Sanger sequencing in all affected and unaffected family members. Sanger sequencing showed that only the rs779393130 mutation in CACNA1C co-segregated with the disease phenotype in this family (Table 3), and no other differentially expressed genes were found in affected or unaffected family members. Then, Sanger sequencing was performed on 50 healthy individuals to detect the CACNA1C variant rs779393130, and no mutation was found at this site in these individuals. The heterozygote CACNA1C (rs779393130) variant, which co-segregated with the ataxia phenotype in the family, may be the mutation causing ADCA in this family.

In this study, we found that a mutation in CACNA1C, a gene that encodes the Cav1.2 subunit of an L-type calcium channel, may be related to ADCA in a Chinese family. Dysfunction of ion channels plays a key role in the pathogenesis of ataxia and related diseases. CACNA1A (MIM: 601011) was the first channel-coding gene reported to be involved in ADCA. Mutation in CACNA1A can lead to spinocerebellar ataxia (SCA) type 6 [SCA6 (MIM: 183086)], episodic ataxia type 2 (MIM: 108500), and familial hemiplegic migraine type 1 (MIM: 141500)^[8,9]. In recent years, CACNA1G has been shown to be a pathogenic gene in ADCA [SCA42 (MIM: 604065)] ^[10-12^]. Potassium channel mutations have been described in SCA13 (MIM: 605259) and SCA19/22 (MIM: 607346). Episodic ataxia (EA) is associated with SCA, and mutations in calcium channel genes may lead to EA; for example, mutations in CACNA1A and CACNB4 lead to EA2 (MIM: 108500) and EA5 (MIM: 613855), respectively ^[13,14].

The Cav1.2 protein is composed primarily of α1C, α2δ, intracellular β, and CaM subunits, and it plays an important role in the development of dendrites, neuron survival, synaptic plasticity, and memory formation. Studies suggest that Cav1.2 is involved in changes in the calcium permeability of cell membranes, leading to changes in intracellular signaling pathway activity, gene transcription, and synaptic plasticity in the adjustment of advanced brain complex functions such as cognition, emotion, and behavior. Thus, CACNA1C is a promising candidate gene for psychiatric disorders, seizures, and migraine ^[15,16]. It has been reported, in a mouse model of ataxia and epilepsy, that cerebellar calcium channel proteins such as Cav1.2 were significantly reduced in number, and thus we speculate that CACNA1C is associated with cerebellar ataxia. Based on whole-exome sequencing and Sanger sequencing, we proposed that CACNA1C is the causative gene of ADCA in this family ^[17]. In fact, the rs779393130 SNP is located in an intron, and no pathogenicity reports have been reported. However, our preliminary study found that the SNP co-segregated with the ataxia phenotype in this family. Therefore, we believe that the SNP may be associated with the disease phenotype. Functional validation of animal and cell experiments will be conducted in the future. We will explore the function of the SNP and whether it can affect the phenotype of the disease.

Conclusions

A combination of clinical evaluation and genetic analyses is recommended in the diagnosis of HA subtypes. Because HA is incurable, it is important to identify the causative genes at additional disease loci to improve patients’ function and quality of life. Further research is needed to elucidate the detailed clinical features of CACNA1C-dependent ADCA.

HA: Hereditary ataxia ; ADCA: autosomal dominant cerebellar ataxia ; ARCA: autosomal recessive cerebellar ataxia; LTCC: L-type voltage-gated calcium channel; EA: Episodic ataxia

Ethics approval and consent to participate: Written informed consent was obtained from each subject prior to inclusion in the study.

Consent for publication: Yes

Availability of data and material: The data and material used and/or analysed during this study are available from the corresponding author on reasonable request.

Competing interests: The authors declare that they have no competing interests.

Funding: None

Authors' contributions: Jia Li analyzed and interpreted the patient data, and was a major contributor in writing the manuscript. Jiajun Chen guided the writing. Xiaoyang Liu, Yajuan Sun helped to analyz and interpret the patient data. All authors read and approved the final manuscript

Acknowledgements：We gratefully acknowledge Yajuan Sun, Xiaoyang Liu. for performing a research on the questions and for conducting the literature search. We thank all the study participants. No financial support has been received for the research, authorship, and/or publication of this article.

1. Matilla-Duenas A, Ashizawa T, Brice A, et al. Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias. Cerebellum. 2014;13, 269–302.

2. Durr A. Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyond. Lancet Neurol. 2010;9, 885–894.

3. Hersheson J, Haworth A and Houlden H. The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum. Mutat. 2012;33, 1324–1332.

4. Klockgether T. Update on degenerative ataxias. Curr Opin Neurol. 2011; 24:339-45.

5. Scho ̈ls L, Bauer P, Schmidt T, et al. Autosomal dominant cerebellar ataxias: Clinical features, genetics, and pathogenesis. Lancet Neurol. 2004; 3:291–304.  

6. Gatchel JR, Zoghbi HY. Diseases of unstable repeat expansion: mechanisms and common principles. Nat Rev Genet. 2015; 6:743–55. 

7. Duenas AM, Goold R, Giunti P. Molecular pathogenesis of spinocerebellar ataxias. Brain. 2006; 129:1357–70.  

8. Giunti P, Mantuano E, Frontali M et al. Molecular mechanism of Spinocerebellar Ataxia type 6: glutamine repeat disorder, channelopathy and transcriptional dysregulation. The multifaceted aspects of a single mutation. Front Cell. Neurosci. 2015;9, 36.

9. Rajakulendran S, Kaski D, and Hanna MG. Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat. Rev. Neurol. 2012;8, 86–96.

10. Hiroyuki Morino1, Yukiko Matsuda, Keiko Muguruma, et al. A mutation in the low voltage-gated calcium channel CACNA1G alters the physiological properties of the channel, causing spinocerebellar ataxia. Molecular Brain. 2015;8:89.

11. Mari K, Ichiro Y, Yuka H, et al. SCA42 mutation analysis in a case series of Japanese patients with spinocerebellar ataxia. Journal of Human Genetics 2017;1–3 

12. Coutelier M, Blesneac I, Monteil A, et al. A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia. The American Journal of Human Genetics. 2015; 97, 726-737

13. Jodice C, Mantuano E, Veneziano L, et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet. 1997;6:1973–8.

14. Escayg A, De Waard M, Lee DD, et al. (2000). Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet. 66:1531–9.

15. Dedic N, Pöhlmann ML, Richter JS, et al. (2017). Cross-disorder risk gene CACNA1C differentially modulates susceptibility to psychiatric disorders during development and adulthood. Molecular Psychiatry 00, 1-11

16. Yoshimizu T, Pan JQ, Mungenast AE, (2014). Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons. Molecular Psychiatry.1–8 

17. Beulah L, Olga S, Diane G, et al. (2009). Loss of calcium channels in the cerebellum of the ataxic and epileptic stargazer mutant mouse. Brain Research 1279;156–167

Table 1 Clinical features of affected family members

Characteristic	II 1	II3	II5	II7	III4
Age at examination	59	53	49	48	26
Age at symptom onset	29	30	28	26	24
Symptoms at onset	gait instability	gait instability	gait instability	gait instability	gait instability
SARA	20	10	12	22	5
Dysarthria	mild	no	mild	moderate	no
Ocular signs	no	no	saccadic pursuit, smooth pursuit defective	saccadic pursuit, smooth pursuit defective	no
Reflexes of Upper limb Lower limb	normal normal	normal normal	Slight hyperreflexia Slight hyperreflexia	normal normal	normal normal
Cerebellar signs in ULs	no	no	moderate	moderate	mild
Gait ataxia	mild	mild	moderate	moderate	mild
Muscle tone	normal	normal	normal	normal	normal
Involuntary movement	no	no	no	no	no
Babinski sign	negative	negative	positive	positive	negative
Cerebral MRI	cerebellar atrophy	NA	cerebellar atrophy	cerebellar atrophy	NA
Other complications	weakness of LLs	no	memory decline	vertigo	no
MoCA	23	24	18	25	28

Table 2 Data output quality list

Sample name	Raw reads	Raw data(G)	Raw depth (x)	Effective (%)	average read length (bp)
II5	14438529	4.33	71.62	99.2	150
II7	14613088	4.38	72.45	99.09	150
III4	14392960	4.32	71.46	99.23	150
III5	17271054	5.18	85.68	98.72	150

Table 3 Genotype analysis

CACNA1C: Single nucleotide polymorphism (SNP) rs779393130

II-1（patient）	C/G	III-4（patient）	C/G
II-5（patient）	C/G	III-3（normal）	C/C
II-3（patient）	C/G	III-5（normal）	C/C
II-7（patient）	C/G	II-6（normal）	C/C

Download PDF

Journal Publication

published 10 Jul, 2019

Read the published version in BMC Neurology →

Editorial decision: Minor revision
18 Jun, 2019
Reviewer #1 agreed at journal
14 Jun, 2019
Review #1 received at journal
14 Jun, 2019
Reviewers invited by journal
11 Jun, 2019
Submission checks completed at journal
30 May, 2019
Editor invited by journal
30 May, 2019
Editor assigned by journal
30 May, 2019

You are reading this older preprint version

Read the latest preprint version →

Identification of a novel mutation in the CACNA1C gene in a Chinese family with autosomal dominant cerebellar ataxia

Status:

Journal Publication

Version 2

Abstract

Figures

Background

Methods

Results

Discussion

Abbreviations

Declaration

References

Tables

Status:

Journal Publication

Version 2